Altre lingue ANI Pharmaceuticals, Inc.

Azioni

ANIP

US00182C1036

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 24/04/2024			Variaz. 5gg	Var. 1 gen.
65,43 ^USD	-1,07%		-0,08%	+18,66%

17/04	L'insider di Ani Pharmaceuticals ha venduto azioni per un valore di 1.500.589 dollari, secondo un recente deposito SEC	MT
09/04	ANI Pharmaceuticals, Inc. annuncia il lancio di Baclofen Sospensione Orale	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET	18/04
Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing	17/04
ANI Pharmaceuticals : Corporate Presentation - April 2024	17/04
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension	09/04
ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension	09/04
ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis	04/04
Ani Pharmaceuticals Insider Sold Shares Worth $1,345,000, According to a Recent SEC Filing	03/04
ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium	03/04
ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP	27/03
ANI Pharmaceuticals, Inc. Announces the Launch of Levofloxacin Oral Solution, USP	27/03
ANI Pharmaceuticals : Corporate Presentation - March 2024	12/03
Ani Pharmaceuticals Insider Sold Shares Worth $671,700, According to a Recent SEC Filing	12/03
Ani Pharmaceuticals Insider Sold Shares Worth $2,630,864, According to a Recent SEC Filing	08/03
Ani Pharmaceuticals Insider Sold Shares Worth $456,400, According to a Recent SEC Filing	06/03
Ani Pharmaceuticals Insider Sold Shares Worth $330,000, According to a Recent SEC Filing	06/03
Sector Update: Health Care Stocks Decline Late Afternoon	29/02
Sector Update: Health Care Stocks Retreat Thursday Afternoon	29/02
ANI Pharmaceuticals Shares Rise After Q4 Adjusted Earnings, Net Revenue Beat Forecasts	29/02
ANI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
ANI: Q4 Earnings Snapshot	29/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue ANI Pharmaceuticals, Inc.

Azioni

ANIP

US00182C1036

Altre lingue

Filtri